Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Exploring interactions between Blastocystis sp., Strongyloides spp. and the gut microbiomes of wild chimpanzees in Senegal.
Reply to Ambrosioni et al.
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
Balances: a New Perspective for Microbiome Analysis.
Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.
T-cell decline in HIV-positive individuals maintained on a failing treatment regimen.
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial.
Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.
HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.